ArticleBMC infectious diseases2025
A case of panophthalmitis with orbital infection of polymicrobial origin.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundInfectious endophthalmitis following penetrating ocular trauma represents an acute and often blinding disease with a generally poor prognosis. The causative pathogens involved are diverse, among which bacterial organisms are the most prevalent. In contrast, infections caused by fungi of the order Mucorales are rare, constituting acute and fulminant opportunistic mycoses. These fungal infections are characterized by an insidious onset and are associated with an exceedingly high mortality rate, particularly in patients with comorbid diabetes mellitus. CASE PRESENTATION: A 60-year-old diabetic male presented with severe, rapidly progressive infectious endophthalmitis after a penetrating ocular injury. Imaging demonstrated substantial destruction of the right eyeball and its adnexa, as well as bony absorption of the medial orbital wall. Intraoperative tissue specimens on day 3 of admission were cultured for Rhizopus arrhizus, Pseudomonas aeruginosa, Enterococcus faecalis. The treatment regimen was guided by pathogen identification and drug susceptibility results. It consisted of systemic intravenous liposomal amphotericin B (L-AmB) and piperacillin-tazobactam, aggressive blood glucose management, topical medication, and two sessions of surgical debridement. By day 28 of admission, the patient was discharged with good recovery, Outpatient follow-up at 10 and 40 days after discharge showed no abnormalities and the prognosis was good.
conclusionsEarly targeted Sanger sequencing identification and multimodal therapy—combining antifungal, antibacterial, and surgical interventions—were critical to overcoming the diagnostic challenges and therapeutic complexities in this immunocompromised host.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.